In 2023, Medikaloka Hermina completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Medikaloka Hermina has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0.803a | 2.917a | 1.019a | |
Total Scope 2 | ||||
Unspecified Calculation Method | 35,236,048.986a | 34,457,659.172a | 438,783,451.123a | |
Total Scope 3 | N/A | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0.0021a | 0.0093a | 0.0025a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Medikaloka Hermina’s data sources below and access millions more through our Disclosure Search.
In 2023, the total operational greenhouse gas (GHG) emissions of Medikaloka Hermina amounted to 35,236,049.789 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Medikaloka Hermina increased by 2.26%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2023, the total Scope 1 emissions of Medikaloka Hermina were 0.803 metric tons of CO₂ equivalent (tCO₂e).a
Since 2020, Medikaloka Hermina's Scope 1 emissions have decreased by 25.37%, reflecting a declining long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2022), Medikaloka Hermina's Scope 1 emissions decreased by 72.47%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2023, Medikaloka Hermina reported Scope 2 greenhouse gas (GHG) emissions of 35,236,048.986 tCO₂e without specifying the calculation method.a
Since 2020, Medikaloka Hermina's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 88.66%, reflecting a declining long-term trend in Scope 2 emissions over time.ab
Compared to the previous year (2022), Medikaloka Hermina's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Medikaloka Hermina's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2023, Medikaloka Hermina reported its Scope 2 emissions using an unspecified methodology.a
In 2023, Medikaloka Hermina reported Scope 1 greenhouse gas (GHG) emissions of 0.803 tCO₂e and total revenues of USD 382 millions. This translates into an emissions intensity of 0 tCO₂e per millions USD.a
In 2023, Medikaloka Hermina reported a Scope 1 emissions intensity of 0 tCO₂e per millions USD. Compared to the peer group median of 8.63, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2023, Medikaloka Hermina ranked 1 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Medikaloka Hermina among the top performers, with one of the lowest emissions intensities relative to peers.a